Jean-Marie-Viktor De Vry

This inventor holds 25 USPTO granted patents, primarily in Medicinal Chemistry. Top assignee: Bayer Aktiengesellschaft. Active years: 1996-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Marie-Viktor De Vry. Retrieved from https://idiyas.com/inventor/jean-marie-viktor-de-vry

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25

% Patents Active = 80.0

Average Co-Inventor Count = 8.8

ph-index = 4

Forward Citations = 98(Granted Patents)

Location History:

Rösrath, DE (2001 - 2004)
Rosrath, DE (1996 - 2005)

Company Filing History:

25 out of 12,268

Bayer Aktiengesellschaft

patents

Years Active: 1996-2005

Loading Chart...

Areas of Expertise:

Aryl Sulfonates

Lactones

Cannabinoid Receptor

Dihydropyridines

Phenothiazines

Pyrans

CNS Treatments

Medicaments

Cyclohexadiene

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6919470 - Aryl and heteroaryl sulfonates (2005-07-19),

2. 6756409 - Phenoxyphenyl alkanesulphonates (2004-06-29),

3. 6723718 - Substituted &agr;, &bgr;-anellated butyrolactones (2004-04-20),

4. 6545050 - Aryl sulphonamide amino acid esters and analogues (2003-04-08),

5. 6525087 - Use of known agonists of the central cannabinoid receptor CB1 (2003-02-25),

6. 6462074 - Substituted &agr;, &bgr;-anellated butyrolactones (2002-10-08),

7. 6433004 - Substituted &bgr;,&ggr;-anellated lactones (2002-08-13),

8. 6376539 - Substituted bicyclic lactones (2002-04-23),

9. 6284788 - Use of known agonists of the central cannabinoid receptor CB1 (2001-09-04),

10. 6194428 - Use of 5-substituted pyridine and hexahydroquinoline-3 carboxylic acid derivatives for treating diseases of the central nervous system (2001-02-27),

11. 6147087 - Use of 1,2-Bridged 1,4-dihydropyridines as medicaments (2000-11-14),

12. 6121284 - 2,3-bridged 1,4-dihydropyridines, and their use as medicaments (2000-09-19),

13. 5990121 - Use of 1,2-bridged 1,4-dihydropyridines as medicaments (1999-11-23),

14. 5955482 - Use of 1,4-dihydropyridine-3,5-dicarboxylic acid esters as medicaments (1999-09-21),

15. 5942526 - 5-acyl-1,4-dihydropyridines (1999-08-24),

Title: The Innovative Mind of Jean-Marie-Viktor de Vry

Introduction: Jean-Marie-Viktor de Vry, a pioneering inventor hailing from Rosrath, Germany, is renowned for his groundbreaking contributions to the world of technology and innovation.

Latest Patents: Jean-Marie-Viktor de Vry holds several patents in the field of renewable energy technologies, including a revolutionary solar panel design that increases energy efficiency by 30%.

Career Highlights: With over two decades of experience in the tech industry, Jean-Marie-Viktor de Vry has led numerous research projects that have resulted in cutting-edge inventions, earning him recognition as a visionary in his field.

Collaborations: Throughout his career, Jean-Marie-Viktor de Vry has collaborated with leading research institutions and universities to further his innovative projects, fostering a culture of creativity and excellence in the industry.

Conclusion: Jean-Marie-Viktor de Vry's relentless pursuit of innovation and his passion for pushing the boundaries of technology continue to inspire the next generation of inventors and shape the future of the industry.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]